Veterinary Antimicrobial Susceptibility Testing Market by Product (Disks, Plates, Media, Accessories, Consumables, Automated AST), Animal (Dog, Cat, Horse, Cattle, Pig, Poultry),End User (Veterinary Reference Labs, Universities) - Global Forecast to 2026
Veterinary antimicrobial susceptibility testing is an important tool used by veterinarians to identify pathogens in animals and select the most appropriate antimicrobial agent to treat these diseases and infections. The veterinary antimicrobial susceptibility testing market is expected to reach USD 135 million by 2026 from an estimated USD 100 million in 2021, at a CAGR of 6.1%. Growth in the market is largely driven by the growing threat of antimicrobial resistance due to the overuse of antibiotics, rising demand for animal-derived products, growing prevalence of zoonotic diseases, rising demand for pet insurance, growing animal health expenditure, and the growing number of veterinary practitioners & their rising income levels in developed economies. On the other hand, the high cost of automated veterinary AST systems and rising pet care costs are expected to restrain the overall market growth to a certain extent.
Based on product type, the disks and plates segment holds the largest market share during the forecast period.
Based on products, the veterinary antimicrobial susceptibility testing market is segmented into disks & plates, culture media, accessories & consumables, and automated AST instruments. In 2020, the disks & plates segment accounted for the largest share of the market. The large share of this segment can be attributed to the high utilization of antimicrobial susceptibility tests for the disk diffusion method and the increasing prevalence of infectious diseases in food-producing and companion animals.
Based on animal type, the Food-producing animal segment holds the largest market share during the forecast period.
Based on animal type, the veterinary antimicrobial susceptibility testing market is segmented into food-producing animals and companion animals. The food-producing animals segment accounted for the largest shareof the market in 2020. The large share and high growth of this segment can be attributed to the high use of antibiotics in food-producing animals, increasing incidence of antimicrobial resistance, increasing demand for meat and dairy products, rising animal healthcare expenditure in developed countries, and the increasing incidence of disease outbreaks in food-producing animals. This segment is further categorized into cattle, pigs, poultry, and other food-producing animals. Companion animals are further segmented into dogs, cats, horses, and other companion animals.
Based on end user, the veterinary ASTsegment is expected to register the highest CAGR during the forecast period.
Based on end users, the veterinary antimicrobial susceptibility testing market is segmented into veterinary reference laboratories, veterinary research institutes and universities, and other end users. Veterinary reference laboratories accounted for the largest shareof the market in 2020. The large share of this segment can be attributed to the large number of samples received for AST in reference laboratories from small and large animal practices. This segment is also expected to register the highest growth during the forecast period (2021–2026).
North America is expected to account for the largest share of the veterinary antimicrobial susceptibility testing market in 2020
Geographically, the veterinary antimicrobial susceptibility testing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest shareof the veterinary antimicrobial susceptibility testing market in 2020. The large share of this region is mainly due to the increasing awareness about antimicrobial resistance among veterinarians and livestock farmers, strict government regulations regarding the usage of antimicrobials in livestock animals, availability of advanced veterinary diagnostic laboratories, increasing adoption of pet animals, the growing pet insurance industry, and rising veterinary healthcare expenditure in the region.
Break of primary participants was as mentioned below:
The key players operating in the veterinary antimicrobial susceptibility testingmarketincludeThermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Bruker Corporation (US), bioM?rieux SA (France), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Neogen Corporation (US), HiMedia Laboratories (India), Mast Group Ltd. (UK), Bioguard Corporation (Taiwan), SSI Diagnostica A/S (Denmark), Condalab (Spain), FASTinov SA (Portugal), Synbiosis (UK), Hardy Diagnostics (US), and Liofilchem Srl (Italy).
Research Coverage:
The report analyzes the veterinary antimicrobial susceptibility testing marketand aims at estimating the market size and future growth potential of this market based on various segments such as animal type, product type, end user,andregion. The report also includes aproduct portfolio matrix of various veterinary ASTproductsavailable in the market. The report also providesa competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would helpthem, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies tostrengthen their position in the market.
This report provides insights into the following pointers:
Based on product type, the disks and plates segment holds the largest market share during the forecast period.
Based on products, the veterinary antimicrobial susceptibility testing market is segmented into disks & plates, culture media, accessories & consumables, and automated AST instruments. In 2020, the disks & plates segment accounted for the largest share of the market. The large share of this segment can be attributed to the high utilization of antimicrobial susceptibility tests for the disk diffusion method and the increasing prevalence of infectious diseases in food-producing and companion animals.
Based on animal type, the Food-producing animal segment holds the largest market share during the forecast period.
Based on animal type, the veterinary antimicrobial susceptibility testing market is segmented into food-producing animals and companion animals. The food-producing animals segment accounted for the largest shareof the market in 2020. The large share and high growth of this segment can be attributed to the high use of antibiotics in food-producing animals, increasing incidence of antimicrobial resistance, increasing demand for meat and dairy products, rising animal healthcare expenditure in developed countries, and the increasing incidence of disease outbreaks in food-producing animals. This segment is further categorized into cattle, pigs, poultry, and other food-producing animals. Companion animals are further segmented into dogs, cats, horses, and other companion animals.
Based on end user, the veterinary ASTsegment is expected to register the highest CAGR during the forecast period.
Based on end users, the veterinary antimicrobial susceptibility testing market is segmented into veterinary reference laboratories, veterinary research institutes and universities, and other end users. Veterinary reference laboratories accounted for the largest shareof the market in 2020. The large share of this segment can be attributed to the large number of samples received for AST in reference laboratories from small and large animal practices. This segment is also expected to register the highest growth during the forecast period (2021–2026).
North America is expected to account for the largest share of the veterinary antimicrobial susceptibility testing market in 2020
Geographically, the veterinary antimicrobial susceptibility testing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest shareof the veterinary antimicrobial susceptibility testing market in 2020. The large share of this region is mainly due to the increasing awareness about antimicrobial resistance among veterinarians and livestock farmers, strict government regulations regarding the usage of antimicrobials in livestock animals, availability of advanced veterinary diagnostic laboratories, increasing adoption of pet animals, the growing pet insurance industry, and rising veterinary healthcare expenditure in the region.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–60%, Tier 2–30%, and Tier 3–10%
- By Designation – C-level–30%, Director-level–50%, Others–20%
- By Region – North America–45%, Europe–15%, AsiaPacific–25%, Latin America- 10%, Middle East and Africa–5%
The key players operating in the veterinary antimicrobial susceptibility testingmarketincludeThermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Bruker Corporation (US), bioM?rieux SA (France), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Neogen Corporation (US), HiMedia Laboratories (India), Mast Group Ltd. (UK), Bioguard Corporation (Taiwan), SSI Diagnostica A/S (Denmark), Condalab (Spain), FASTinov SA (Portugal), Synbiosis (UK), Hardy Diagnostics (US), and Liofilchem Srl (Italy).
Research Coverage:
The report analyzes the veterinary antimicrobial susceptibility testing marketand aims at estimating the market size and future growth potential of this market based on various segments such as animal type, product type, end user,andregion. The report also includes aproduct portfolio matrix of various veterinary ASTproductsavailable in the market. The report also providesa competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would helpthem, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies tostrengthen their position in the market.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global veterinary antimicrobial susceptibility testingmarket. The report analyzes this marketbyproduct, animal, and end user
- Product Enhancement/Innovation: Detailed insights on upcoming trends and productlaunches in the global veterinary antimicrobial susceptibility testingmarket
- Market Development: Comprehensive information on the lucrative emerging markets by product, animal, and end user
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in theglobal veterinary antimicrobial susceptibility testingmarket
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in theglobal veterinary antimicrobial susceptibility testingmarket.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.3.3 CURRENCY
1.3.4 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
1.4 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION: BIOM?RIEUX
FIGURE 6 REVENUE ANALYSIS OF TOP 5 COMPANIES: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET (2020)
FIGURE 7 DEMAND-SIDE ANALYSIS
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET (2021–2026)
FIGURE 10 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 LIMITATIONS/RISK ASSESSMENT
2.7 COVID-19 HEALTH ASSESSMENT
2.8 COVID-19 ECONOMIC ASSESSMENT
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 12 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 13 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
3 EXECUTIVE SUMMARY
FIGURE 14 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2021 VS. 2026
FIGURE 15 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2021 VS. 2026
FIGURE 16 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2021 VS. 2026
FIGURE 17 GEOGRAPHIC SNAPSHOT: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
4 PREMIUM INSIGHTS
4.1 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET OVERVIEW
FIGURE 18 GROWING ANIMAL POPULATION AND INCREASING ANIMAL HEALTHCARE EXPENDITURE ARE KEY FACTORS DRIVING MARKET GROWTH
4.2 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT
FIGURE 19 DISKS & PLATES COMMANDED THE LARGEST SHARE OF THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2020
4.3 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: GEOGRAPHIC MIX
FIGURE 20 CHINA TO WITNESS THE HIGHEST GROWTH IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Growing threat of antimicrobial resistance due to overuse of antibiotics
FIGURE 22 SALES AND DISTRIBUTION OF ANTIMICROBIAL DRUGS APPROVED FOR USE IN FOOD-PRODUCING ANIMALS IN THE US (2010–2019)
5.2.1.2 Rising demand for animal-derived food products
TABLE 1 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING REGIONS
TABLE 2 SIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
TABLE 3 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
FIGURE 23 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN THE WORLD
IN 2018
5.2.1.3 Growing prevalence of zoonotic diseases
TABLE 4 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019)
5.2.1.4 Rising demand for pet insurance and growing animal health expenditure
FIGURE 24 US: PET INDUSTRY EXPENDITURE, 2010–2019
5.2.1.5 Growing number of veterinary practitioners & their rising income levels in developed economies
TABLE 5 NUMBER OF VETERINARIANS AND PARA-VETERINARIANS IN DEVELOPED COUNTRIES, 2012–2018
TABLE 6 MARKET DRIVERS: IMPACT ANALYSIS
5.2.2 MARKET RESTRAINTS
5.2.2.1 High cost of automated veterinary antimicrobial susceptibility testing systems
5.2.2.2 Rising pet care costs
TABLE 7 MARKET RESTRAINTS: IMPACT ANALYSIS
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Rising focus on veterinary antimicrobial susceptibility testing in emerging markets due to supportive government initiatives
5.2.3.2 Growth in the companion animal population
TABLE 8 PET POPULATION, BY ANIMAL, 2014–2018 (MILLION)
TABLE 9 MARKET OPPORTUNITY: IMPACT ANALYSIS
5.2.4 MARKET CHALLENGES
5.2.4.1 Low awareness about antimicrobial resistance in veterinarians and livestock farmers
5.2.4.2 Limited guidelines for interpretation of veterinary antimicrobial susceptibility test results
5.2.4.3 Shortage of veterinary practitioners and skilled veterinary pathologists in developing markets
TABLE 10 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS. 2014 VS. 2018
TABLE 11 MARKET CHALLENGES: IMPACT ANALYSIS
5.3 TECHNOLOGICAL ANALYSIS
FIGURE 25 TECHNOLOGICAL ADVANCEMENTS ARE A MAJOR TREND IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
5.4 PRICING ANALYSIS
TABLE 12 REGIONAL PRICING ANALYSIS OF AUTOMATED AST INSTRUMENTS, 2019 (USD)
5.5 VALUE CHAIN ANALYSIS
FIGURE 26 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM MARKET MAP
FIGURE 27 VETERINARY ANTIMICROBIAL SENSITIVITY TESTING MARKET: ECOSYSTEM MARKET MAP
FIGURE 28 VETERINARY ANTIMICROBIAL SENSITIVITY TESTING MARKET: ECOSYSTEM MARKET MAP
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 13 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT FROM NEW ENTRANTS
5.7.2 INTENSITY OF COMPETITIVE RIVALRY
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 BARGAINING POWER OF SUPPLIERS
5.7.5 THREAT FROM SUBSTITUTES
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 29 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: SUPPLY CHAIN ANALYSIS
5.9 IMPACT OF COVID-19 ON THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
5.10 REGULATORY ANALYSIS
5.11 PATENT ANALYSIS
5.11.1 PATENT PUBLICATION TRENDS FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING INSTRUMENTS
FIGURE 30 PATENT PUBLICATION TRENDS (2015–2020)
5.11.2 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING INSTRUMENTS
FIGURE 31 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING INSTRUMENTS (2015–2021)
5.12 DIFFERENCE BETWEEN 96-WELL PLATES AND 384-WELL PLATES
TABLE 14 DIFFERENCE BETWEEN 96-WELL PLATES AND 384-WELL PLATES
5.13 CUSTOMIZED VS. PORTFOLIO PRODUCTS
6 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 15 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 DISKS & PLATES
6.2.1 DISKS & PLATES ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET IN 2020
TABLE 16 LEADING DISKS & PLATES AVAILABLE IN THE MARKET FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING (2020)
TABLE 17 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR DISKS & PLATES, BY COUNTRY, 2019–2026 (USD MILLION)
6.3 CULTURE MEDIA
6.3.1 CONSTANT REQUIREMENT AND REPETITIVE PURCHASE OF CULTURE MEDIA TO DRIVE MARKET GROWTH
TABLE 18 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CULTURE MEDIA, BY COUNTRY, 2019–2026 (USD MILLION)
6.4 ACCESSORIES & CONSUMABLES
6.4.1 WIDE USE OF MANUAL METHODS LIKE DISK DIFFUSION WILL DRIVE THE GROWTH OF THIS SEGMENT
TABLE 19 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR ACCESSORIES & CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION)
6.5 AUTOMATED AST INSTRUMENTS
6.5.1 ONGOING TREND OF LABORATORY AUTOMATION TO DRIVE GROWTH IN THIS MARKET SEGMENT
TABLE 20 ADVANTAGES OF AUTOMATED AST OVER DISKS & PLATES
TABLE 21 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR AUTOMATED AST INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)
7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE
7.1 INTRODUCTION
TABLE 22 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
7.2 FOOD-PRODUCING ANIMALS
FIGURE 32 MARKET FOR CATTLE TO DOMINATE THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS DURING THE FORECAST PERIOD
TABLE 23 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 24 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.1 CATTLE
7.2.1.1 Increasing cattle population and growing consumption of meat to drive growth in the veterinary AST market
TABLE 25 EXAMPLES OF CATTLE-RELATED AMR HUMAN HEALTH THREATS
TABLE 26 CATTLE POPULATION, BY COUNTRY, 2012–2019 (MILLION)
TABLE 27 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CATTLE, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2 PIGS
7.2.2.1 Growing incidence of infectious diseases will support market growth
TABLE 28 SWINE POPULATION, BY COUNTRY, 2012–2019 (MILLION)
FIGURE 33 PER CAPITA PORK CONSUMPTION, 2006–2018 (POUNDS)
TABLE 29 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR PIGS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.3 POULTRY
7.2.3.1 Growing infectious disease prevalence in poultry will support the growth of the veterinary antimicrobial susceptibility testing market
FIGURE 34 PER CAPITA POULTRY MEAT CONSUMPTION, 2006–2018 (POUNDS)
TABLE 30 POULTRY POPULATION, BY COUNTRY, 2012–2019 (MILLION)
TABLE 31 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR POULTRY, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.4 OTHER FOOD-PRODUCING ANIMALS
TABLE 32 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 COMPANION ANIMALS
TABLE 33 POPULATION OF DOGS AND CATS, BY COUNTRY, 2012–2019 (MILLION)
FIGURE 35 MARKET FOR DOGS TO REGISTER THE HIGHEST GROWTH IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS DURING THE FORECAST PERIOD
TABLE 34 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 35 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1 DOGS
7.3.1.1 Dogs dominate the veterinary antimicrobial susceptibility testing market for companion animals
TABLE 36 DOG POPULATION, BY COUNTRY, 2012–2019 (MILLION)
TABLE 37 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR DOGS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.2 CATS
7.3.2.1 Increasing pet cat population to drive market growth
TABLE 38 CAT POPULATION, BY COUNTRY, 2012–2019 (MILLION)
TABLE 39 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CATS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.3 HORSES
7.3.3.1 Growing equine health awareness will drive the market growth
TABLE 40 EQUINE POPULATION, BY COUNTRY, 2012–2019 (THOUSAND)
TABLE 41 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR HORSES, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.4 OTHER COMPANION ANIMALS
TABLE 42 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
8 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER
8.1 INTRODUCTION
TABLE 43 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 VETERINARY REFERENCE LABORATORIES
8.2.1 VETERINARY REFERENCE LABORATORIES ARE THE LARGEST END USERS OF VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTS
TABLE 44 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 VETERINARY RESEARCH INSTITUTES AND UNIVERSITIES
8.3.1 INCREASING FUNDING FOR RESEARCH ON ANTIMICROBIAL RESISTANCE AND AST IN UNIVERSITIES TO BOOST MARKET GROWTH
TABLE 45 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR VETERINARY RESEARCH INSTITUTES AND UNIVERSITIES, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 OTHER END USERS
TABLE 46 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
9 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 36 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 47 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 37 EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA
FIGURE 38 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT
TABLE 48 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 49 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 50 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 51 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 52 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 53 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominated the North American veterinary antimicrobial susceptibility testing market in 2020
FIGURE 39 US: EXPENDITURE ON VET VISITS
FIGURE 40 US: NUMBER OF VETERINARIANS, 2014–2019
TABLE 54 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION)
FIGURE 41 DOMESTIC SALES AND DISTRIBUTION OF MEDICALLY IMPORTANT ANTIMICROBIAL DRUGS FOR PRODUCTION AND THERAPEUTIC INDICATIONS IN THE US (THOUSAND KG)
TABLE 55 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014 VS. 2019
TABLE 56 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 57 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 58 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 59 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 60 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Slow economic growth in Canada severely affects its share in the North American Market
TABLE 61 CANADA: LARGE ANIMAL POPULATION, 2001–2014 (MILLION)
TABLE 62 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 63 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 64 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 65 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 66 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3 EUROPE
TABLE 67 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 68 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 69 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 70 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 71 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 72 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.1 UK
9.3.1.1 The UK is the largest market for veterinary antimicrobial susceptibility testing in Europe
FIGURE 42 SALES OF ANTIBIOTICS FOR FOOD-PRODUCING ANIMALS IN THE UK FROM 2015 TO 2019 (MG/KG)
TABLE 73 UK: PET POPULATION, 2016–2019 (MILLION)
FIGURE 43 NUMBER OF PRACTICING VETERINARIANS IN THE UK, 2013–2017
TABLE 74 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 75 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 76 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 77 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 78 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Strict government regulations for AST to drive market growth in Germany
FIGURE 44 SALES SURVEILLANCE OF ANTIMICROBIALS FOR VETERINARY USE IN GERMANY (2011–2018)
TABLE 79 GERMANY: PET POPULATION, 2012–2019 (MILLION)
TABLE 80 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 81 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 82 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 83 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 84 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Mandatory AST before prescribing antibiotics in animals to drive market growth
TABLE 85 FRANCE: COMPANION ANIMAL POPULATION, 2010–2019 (MILLION)
TABLE 86 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 87 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 88 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 90 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing food-producing animal population and growing awareness of AMR will generate high demand for AST in Italy
TABLE 91 ITALY: LARGE ANIMAL POPULATION, 2001–2019 (MILLION)
TABLE 92 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 93 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 94 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 95 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 96 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing demand for good quality animal-based food products is a major factor driving market growth
TABLE 97 SPAIN: LARGE ANIMAL POPULATION, 2001–2019 (MILLION)
TABLE 98 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 99 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 100 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 101 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.6 REST OF EUROPE (ROE)
TABLE 103 COMPANION ANIMAL OWNERSHIP IN THE REST OF EUROPE, 2018 (MILLION)
TABLE 104 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 105 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 106 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 107 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 108 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC (APAC)
TABLE 109 APAC: FOOD-PRODUCING ANIMAL POPULATION, 2010–2018 (MILLION)
FIGURE 45 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT
TABLE 110 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 111 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 112 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 113 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 114 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 115 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China dominated the APAC veterinary antimicrobial susceptibility testing market in 2020
TABLE 116 CHINA: FOOD-PRODUCING ANIMAL POPULATION, 2012–2019 (MILLION)
TABLE 117 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 118 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 119 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 120 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 121 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Increasing risk of AMR due to high use of antimicrobial feed additives drives the market growth in Japan
FIGURE 46 VOLUME OF VETERINARY ANTIMICROBIALS SOLD BY PHARMACEUTICAL COMPANIES IN JAPAN, 2001–2017 (IN TONS OF ACTIVE INGREDIENT)
FIGURE 47 AMOUNT OF ANTIMICROBIAL FEED ADDITIVES MANUFACTURED IN JAPAN, 2003–2017 (IN TONS OF ACTIVE INGREDIENT)
TABLE 122 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 123 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 124 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 126 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Rising food-producing animal population and growing awareness about animal health will contribute to market growth during the forecast period
TABLE 127 INDIA: FOOD-PRODUCING ANIMAL POPULATION, 2010–2019 (MILLION)
TABLE 128 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 129 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 130 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 131 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 132 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4 ROAPAC
TABLE 133 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 134 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 135 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 136 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 INCREASING BEEF AND POULTRY MEAT EXPORTS SUPPORTS THE MARKET GROWTH
TABLE 138 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 139 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 140 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 141 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 142 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 AVAILABILITY OF FUNDING TO PROMOTE ANIMAL HEALTHCARE IN THIS REGION SUPPORTS OVERALL MARKET GROWTH
TABLE 143 MIDDLE EAST: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, BY COUNTRY (2016 VS. 2018)
TABLE 144 AFRICA: NUMBER OF VETERINARIANS, 2010 VS. 2014 VS. 2016
TABLE 145 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 146 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 147 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 148 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 149 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 KEY PLAYER STRATEGIES
FIGURE 48 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN 2017 AND 2021 (JANUARY)
10.2 MARKET EVALUATION FRAMEWORK
FIGURE 49 MARKET EVALUATION FRAMEWORK: MARKET CONSOLIDATION THROUGH PARTNERSHIPS, COLLABORATIONS, ACQUISITIONS, AND AGREEMENTS
10.3 REVENUE ANALYSIS
FIGURE 50 REVENUE ANALYSIS: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, 2020
10.4 MARKET SHARE ANALYSIS
FIGURE 51 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
TABLE 150 COMPETITION ANALYSIS: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, 2020
10.5 COMPANY EVALUATION QUADRANT/DIVE MATRIX
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 52 COMPANY EVALUATION QUADRANT/DIVE MATRIX: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
FIGURE 53 COMPANY PRODUCT FOOTPRINT: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
10.6 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: GEOGRAPHICAL ASSESSMENT
FIGURE 54 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET (2020)
10.7 COMPETITIVE SITUATION AND TRENDS
10.7.1 PRODUCT LAUNCHES & ENHANCEMENTS
TABLE 151 PRODUCT LAUNCHES & ENHANCEMENTS (2017 – JANUARY 2021)
10.7.2 DEALS
TABLE 152 DEALS (2017–JANUARY 2021)
11 COMPANY PROFILES
11.1 SUPPLY-SIDE PLAYERS
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 153 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 55 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC (2019)
11.1.2 BECTON, DICKINSON AND COMPANY
TABLE 154 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 56 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY (2020)
11.1.3 BRUKER CORPORATION
TABLE 155 BRUKER CORPORATION: BUSINESS OVERVIEW
FIGURE 57 COMPANY SNAPSHOT: BRUKER CORPORATION (2019)
11.1.4 BIOM?RIEUX SA.
TABLE 156 BIOM?RIEUX: BUSINESS OVERVIEW
FIGURE 58 COMPANY SNAPSHOT: BIOM?RIEUX S.A. (2019)
11.1.5 DANAHER CORPORATION
TABLE 157 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 59 COMPANY SNAPSHOT: DANAHER CORPORATION (2019)
11.1.6 BIO-RAD LABORATORIES, INC.
TABLE 158 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
FIGURE 60 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2020)
11.1.7 NEOGEN CORPORATION
TABLE 159 NEOGEN CORPORATION: BUSINESS OVERVIEW
FIGURE 61 COMPANY SNAPSHOT: NEOGEN CORPORATION (2020)
11.1.8 HIMEDIA LABORATORIES
TABLE 160 HIMEDIA LABORATORIES: BUSINESS OVERVIEW
11.1.9 MAST GROUP LTD.
TABLE 161 MAST GROUP LTD.: BUSINESS OVERVIEW
11.1.10 BIOGUARD CORPORATION
TABLE 162 BIOGUARD CORPORATION: BUSINESS OVERVIEW
11.1.11 SSI DIAGNOSTICA A/S
TABLE 163 SSI DIAGNOSTICA A/S: BUSINESS OVERVIEW
11.1.12 CONDALAB
TABLE 164 CONDALAB: BUSINESS OVERVIEW
11.1.13 FASTINOV SA
TABLE 165 FASTINOV SA: BUSINESS OVERVIEW
11.1.14 SYNBIOSIS
TABLE 166 SYNBIOSIS: BUSINESS OVERVIEW
11.1.15 HARDY DIAGNOSTICS
TABLE 167 HARDY DIAGNOSTICS: BUSINESS OVERVIEW
11.1.16 LIOFILCHEM SRL.
TABLE 168 LIOFILCHEM SRL: BUSINESS OVERVIEW
11.2 DEMAND-SIDE PLAYERS
11.2.1 IDEXX REFERENCE LABORATORIES
TABLE 169 IDEXX LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 62 COMPANY SNAPSHOT: IDEXX LABORATORIES, INC. (2020)
11.2.2 UNIVERSITY OF MINNESOTA (VETERINARY DIAGNOSTIC LABORATORY)
11.2.3 IOWA STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY)
11.2.4 CORNELL UNIVERSITY (ANIMAL HEALTH DIAGNOSTIC CENTER)
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.3.3 CURRENCY
1.3.4 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
1.4 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION: BIOM?RIEUX
FIGURE 6 REVENUE ANALYSIS OF TOP 5 COMPANIES: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET (2020)
FIGURE 7 DEMAND-SIDE ANALYSIS
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET (2021–2026)
FIGURE 10 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 LIMITATIONS/RISK ASSESSMENT
2.7 COVID-19 HEALTH ASSESSMENT
2.8 COVID-19 ECONOMIC ASSESSMENT
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 12 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 13 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
3 EXECUTIVE SUMMARY
FIGURE 14 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2021 VS. 2026
FIGURE 15 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2021 VS. 2026
FIGURE 16 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2021 VS. 2026
FIGURE 17 GEOGRAPHIC SNAPSHOT: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
4 PREMIUM INSIGHTS
4.1 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET OVERVIEW
FIGURE 18 GROWING ANIMAL POPULATION AND INCREASING ANIMAL HEALTHCARE EXPENDITURE ARE KEY FACTORS DRIVING MARKET GROWTH
4.2 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT
FIGURE 19 DISKS & PLATES COMMANDED THE LARGEST SHARE OF THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2020
4.3 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: GEOGRAPHIC MIX
FIGURE 20 CHINA TO WITNESS THE HIGHEST GROWTH IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Growing threat of antimicrobial resistance due to overuse of antibiotics
FIGURE 22 SALES AND DISTRIBUTION OF ANTIMICROBIAL DRUGS APPROVED FOR USE IN FOOD-PRODUCING ANIMALS IN THE US (2010–2019)
5.2.1.2 Rising demand for animal-derived food products
TABLE 1 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING REGIONS
TABLE 2 SIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
TABLE 3 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
FIGURE 23 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN THE WORLD
IN 2018
5.2.1.3 Growing prevalence of zoonotic diseases
TABLE 4 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019)
5.2.1.4 Rising demand for pet insurance and growing animal health expenditure
FIGURE 24 US: PET INDUSTRY EXPENDITURE, 2010–2019
5.2.1.5 Growing number of veterinary practitioners & their rising income levels in developed economies
TABLE 5 NUMBER OF VETERINARIANS AND PARA-VETERINARIANS IN DEVELOPED COUNTRIES, 2012–2018
TABLE 6 MARKET DRIVERS: IMPACT ANALYSIS
5.2.2 MARKET RESTRAINTS
5.2.2.1 High cost of automated veterinary antimicrobial susceptibility testing systems
5.2.2.2 Rising pet care costs
TABLE 7 MARKET RESTRAINTS: IMPACT ANALYSIS
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Rising focus on veterinary antimicrobial susceptibility testing in emerging markets due to supportive government initiatives
5.2.3.2 Growth in the companion animal population
TABLE 8 PET POPULATION, BY ANIMAL, 2014–2018 (MILLION)
TABLE 9 MARKET OPPORTUNITY: IMPACT ANALYSIS
5.2.4 MARKET CHALLENGES
5.2.4.1 Low awareness about antimicrobial resistance in veterinarians and livestock farmers
5.2.4.2 Limited guidelines for interpretation of veterinary antimicrobial susceptibility test results
5.2.4.3 Shortage of veterinary practitioners and skilled veterinary pathologists in developing markets
TABLE 10 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS. 2014 VS. 2018
TABLE 11 MARKET CHALLENGES: IMPACT ANALYSIS
5.3 TECHNOLOGICAL ANALYSIS
FIGURE 25 TECHNOLOGICAL ADVANCEMENTS ARE A MAJOR TREND IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
5.4 PRICING ANALYSIS
TABLE 12 REGIONAL PRICING ANALYSIS OF AUTOMATED AST INSTRUMENTS, 2019 (USD)
5.5 VALUE CHAIN ANALYSIS
FIGURE 26 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM MARKET MAP
FIGURE 27 VETERINARY ANTIMICROBIAL SENSITIVITY TESTING MARKET: ECOSYSTEM MARKET MAP
FIGURE 28 VETERINARY ANTIMICROBIAL SENSITIVITY TESTING MARKET: ECOSYSTEM MARKET MAP
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 13 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT FROM NEW ENTRANTS
5.7.2 INTENSITY OF COMPETITIVE RIVALRY
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 BARGAINING POWER OF SUPPLIERS
5.7.5 THREAT FROM SUBSTITUTES
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 29 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: SUPPLY CHAIN ANALYSIS
5.9 IMPACT OF COVID-19 ON THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
5.10 REGULATORY ANALYSIS
5.11 PATENT ANALYSIS
5.11.1 PATENT PUBLICATION TRENDS FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING INSTRUMENTS
FIGURE 30 PATENT PUBLICATION TRENDS (2015–2020)
5.11.2 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING INSTRUMENTS
FIGURE 31 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING INSTRUMENTS (2015–2021)
5.12 DIFFERENCE BETWEEN 96-WELL PLATES AND 384-WELL PLATES
TABLE 14 DIFFERENCE BETWEEN 96-WELL PLATES AND 384-WELL PLATES
5.13 CUSTOMIZED VS. PORTFOLIO PRODUCTS
6 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 15 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 DISKS & PLATES
6.2.1 DISKS & PLATES ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET IN 2020
TABLE 16 LEADING DISKS & PLATES AVAILABLE IN THE MARKET FOR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING (2020)
TABLE 17 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR DISKS & PLATES, BY COUNTRY, 2019–2026 (USD MILLION)
6.3 CULTURE MEDIA
6.3.1 CONSTANT REQUIREMENT AND REPETITIVE PURCHASE OF CULTURE MEDIA TO DRIVE MARKET GROWTH
TABLE 18 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CULTURE MEDIA, BY COUNTRY, 2019–2026 (USD MILLION)
6.4 ACCESSORIES & CONSUMABLES
6.4.1 WIDE USE OF MANUAL METHODS LIKE DISK DIFFUSION WILL DRIVE THE GROWTH OF THIS SEGMENT
TABLE 19 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR ACCESSORIES & CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION)
6.5 AUTOMATED AST INSTRUMENTS
6.5.1 ONGOING TREND OF LABORATORY AUTOMATION TO DRIVE GROWTH IN THIS MARKET SEGMENT
TABLE 20 ADVANTAGES OF AUTOMATED AST OVER DISKS & PLATES
TABLE 21 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR AUTOMATED AST INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)
7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE
7.1 INTRODUCTION
TABLE 22 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
7.2 FOOD-PRODUCING ANIMALS
FIGURE 32 MARKET FOR CATTLE TO DOMINATE THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS DURING THE FORECAST PERIOD
TABLE 23 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 24 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.1 CATTLE
7.2.1.1 Increasing cattle population and growing consumption of meat to drive growth in the veterinary AST market
TABLE 25 EXAMPLES OF CATTLE-RELATED AMR HUMAN HEALTH THREATS
TABLE 26 CATTLE POPULATION, BY COUNTRY, 2012–2019 (MILLION)
TABLE 27 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CATTLE, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2 PIGS
7.2.2.1 Growing incidence of infectious diseases will support market growth
TABLE 28 SWINE POPULATION, BY COUNTRY, 2012–2019 (MILLION)
FIGURE 33 PER CAPITA PORK CONSUMPTION, 2006–2018 (POUNDS)
TABLE 29 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR PIGS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.3 POULTRY
7.2.3.1 Growing infectious disease prevalence in poultry will support the growth of the veterinary antimicrobial susceptibility testing market
FIGURE 34 PER CAPITA POULTRY MEAT CONSUMPTION, 2006–2018 (POUNDS)
TABLE 30 POULTRY POPULATION, BY COUNTRY, 2012–2019 (MILLION)
TABLE 31 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR POULTRY, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.4 OTHER FOOD-PRODUCING ANIMALS
TABLE 32 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 COMPANION ANIMALS
TABLE 33 POPULATION OF DOGS AND CATS, BY COUNTRY, 2012–2019 (MILLION)
FIGURE 35 MARKET FOR DOGS TO REGISTER THE HIGHEST GROWTH IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS DURING THE FORECAST PERIOD
TABLE 34 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 35 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1 DOGS
7.3.1.1 Dogs dominate the veterinary antimicrobial susceptibility testing market for companion animals
TABLE 36 DOG POPULATION, BY COUNTRY, 2012–2019 (MILLION)
TABLE 37 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR DOGS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.2 CATS
7.3.2.1 Increasing pet cat population to drive market growth
TABLE 38 CAT POPULATION, BY COUNTRY, 2012–2019 (MILLION)
TABLE 39 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CATS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.3 HORSES
7.3.3.1 Growing equine health awareness will drive the market growth
TABLE 40 EQUINE POPULATION, BY COUNTRY, 2012–2019 (THOUSAND)
TABLE 41 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR HORSES, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.4 OTHER COMPANION ANIMALS
TABLE 42 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
8 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER
8.1 INTRODUCTION
TABLE 43 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 VETERINARY REFERENCE LABORATORIES
8.2.1 VETERINARY REFERENCE LABORATORIES ARE THE LARGEST END USERS OF VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTS
TABLE 44 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 VETERINARY RESEARCH INSTITUTES AND UNIVERSITIES
8.3.1 INCREASING FUNDING FOR RESEARCH ON ANTIMICROBIAL RESISTANCE AND AST IN UNIVERSITIES TO BOOST MARKET GROWTH
TABLE 45 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR VETERINARY RESEARCH INSTITUTES AND UNIVERSITIES, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 OTHER END USERS
TABLE 46 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
9 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 36 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 47 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 37 EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA
FIGURE 38 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT
TABLE 48 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 49 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 50 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 51 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 52 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 53 NORTH AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominated the North American veterinary antimicrobial susceptibility testing market in 2020
FIGURE 39 US: EXPENDITURE ON VET VISITS
FIGURE 40 US: NUMBER OF VETERINARIANS, 2014–2019
TABLE 54 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION)
FIGURE 41 DOMESTIC SALES AND DISTRIBUTION OF MEDICALLY IMPORTANT ANTIMICROBIAL DRUGS FOR PRODUCTION AND THERAPEUTIC INDICATIONS IN THE US (THOUSAND KG)
TABLE 55 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014 VS. 2019
TABLE 56 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 57 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 58 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 59 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 60 US: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Slow economic growth in Canada severely affects its share in the North American Market
TABLE 61 CANADA: LARGE ANIMAL POPULATION, 2001–2014 (MILLION)
TABLE 62 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 63 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 64 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 65 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 66 CANADA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3 EUROPE
TABLE 67 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 68 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 69 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 70 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 71 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 72 EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.1 UK
9.3.1.1 The UK is the largest market for veterinary antimicrobial susceptibility testing in Europe
FIGURE 42 SALES OF ANTIBIOTICS FOR FOOD-PRODUCING ANIMALS IN THE UK FROM 2015 TO 2019 (MG/KG)
TABLE 73 UK: PET POPULATION, 2016–2019 (MILLION)
FIGURE 43 NUMBER OF PRACTICING VETERINARIANS IN THE UK, 2013–2017
TABLE 74 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 75 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 76 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 77 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 78 UK: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Strict government regulations for AST to drive market growth in Germany
FIGURE 44 SALES SURVEILLANCE OF ANTIMICROBIALS FOR VETERINARY USE IN GERMANY (2011–2018)
TABLE 79 GERMANY: PET POPULATION, 2012–2019 (MILLION)
TABLE 80 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 81 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 82 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 83 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 84 GERMANY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Mandatory AST before prescribing antibiotics in animals to drive market growth
TABLE 85 FRANCE: COMPANION ANIMAL POPULATION, 2010–2019 (MILLION)
TABLE 86 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 87 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 88 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 90 FRANCE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing food-producing animal population and growing awareness of AMR will generate high demand for AST in Italy
TABLE 91 ITALY: LARGE ANIMAL POPULATION, 2001–2019 (MILLION)
TABLE 92 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 93 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 94 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 95 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 96 ITALY: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing demand for good quality animal-based food products is a major factor driving market growth
TABLE 97 SPAIN: LARGE ANIMAL POPULATION, 2001–2019 (MILLION)
TABLE 98 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 99 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 100 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 101 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 SPAIN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.6 REST OF EUROPE (ROE)
TABLE 103 COMPANION ANIMAL OWNERSHIP IN THE REST OF EUROPE, 2018 (MILLION)
TABLE 104 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 105 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 106 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 107 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 108 REST OF EUROPE: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC (APAC)
TABLE 109 APAC: FOOD-PRODUCING ANIMAL POPULATION, 2010–2018 (MILLION)
FIGURE 45 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT
TABLE 110 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 111 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 112 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 113 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 114 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 115 ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China dominated the APAC veterinary antimicrobial susceptibility testing market in 2020
TABLE 116 CHINA: FOOD-PRODUCING ANIMAL POPULATION, 2012–2019 (MILLION)
TABLE 117 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 118 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 119 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 120 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 121 CHINA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Increasing risk of AMR due to high use of antimicrobial feed additives drives the market growth in Japan
FIGURE 46 VOLUME OF VETERINARY ANTIMICROBIALS SOLD BY PHARMACEUTICAL COMPANIES IN JAPAN, 2001–2017 (IN TONS OF ACTIVE INGREDIENT)
FIGURE 47 AMOUNT OF ANTIMICROBIAL FEED ADDITIVES MANUFACTURED IN JAPAN, 2003–2017 (IN TONS OF ACTIVE INGREDIENT)
TABLE 122 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 123 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 124 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 126 JAPAN: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Rising food-producing animal population and growing awareness about animal health will contribute to market growth during the forecast period
TABLE 127 INDIA: FOOD-PRODUCING ANIMAL POPULATION, 2010–2019 (MILLION)
TABLE 128 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 129 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 130 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 131 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 132 INDIA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4 ROAPAC
TABLE 133 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 134 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 135 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 136 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 REST OF ASIA PACIFIC: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 INCREASING BEEF AND POULTRY MEAT EXPORTS SUPPORTS THE MARKET GROWTH
TABLE 138 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 139 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 140 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 141 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 142 LATIN AMERICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 AVAILABILITY OF FUNDING TO PROMOTE ANIMAL HEALTHCARE IN THIS REGION SUPPORTS OVERALL MARKET GROWTH
TABLE 143 MIDDLE EAST: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, BY COUNTRY (2016 VS. 2018)
TABLE 144 AFRICA: NUMBER OF VETERINARIANS, 2010 VS. 2014 VS. 2016
TABLE 145 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 146 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 147 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 148 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 149 MIDDLE EAST & AFRICA: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 KEY PLAYER STRATEGIES
FIGURE 48 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN 2017 AND 2021 (JANUARY)
10.2 MARKET EVALUATION FRAMEWORK
FIGURE 49 MARKET EVALUATION FRAMEWORK: MARKET CONSOLIDATION THROUGH PARTNERSHIPS, COLLABORATIONS, ACQUISITIONS, AND AGREEMENTS
10.3 REVENUE ANALYSIS
FIGURE 50 REVENUE ANALYSIS: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, 2020
10.4 MARKET SHARE ANALYSIS
FIGURE 51 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
TABLE 150 COMPETITION ANALYSIS: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, 2020
10.5 COMPANY EVALUATION QUADRANT/DIVE MATRIX
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 52 COMPANY EVALUATION QUADRANT/DIVE MATRIX: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
FIGURE 53 COMPANY PRODUCT FOOTPRINT: VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
10.6 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: GEOGRAPHICAL ASSESSMENT
FIGURE 54 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET (2020)
10.7 COMPETITIVE SITUATION AND TRENDS
10.7.1 PRODUCT LAUNCHES & ENHANCEMENTS
TABLE 151 PRODUCT LAUNCHES & ENHANCEMENTS (2017 – JANUARY 2021)
10.7.2 DEALS
TABLE 152 DEALS (2017–JANUARY 2021)
11 COMPANY PROFILES
11.1 SUPPLY-SIDE PLAYERS
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 153 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 55 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC (2019)
11.1.2 BECTON, DICKINSON AND COMPANY
TABLE 154 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 56 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY (2020)
11.1.3 BRUKER CORPORATION
TABLE 155 BRUKER CORPORATION: BUSINESS OVERVIEW
FIGURE 57 COMPANY SNAPSHOT: BRUKER CORPORATION (2019)
11.1.4 BIOM?RIEUX SA.
TABLE 156 BIOM?RIEUX: BUSINESS OVERVIEW
FIGURE 58 COMPANY SNAPSHOT: BIOM?RIEUX S.A. (2019)
11.1.5 DANAHER CORPORATION
TABLE 157 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 59 COMPANY SNAPSHOT: DANAHER CORPORATION (2019)
11.1.6 BIO-RAD LABORATORIES, INC.
TABLE 158 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
FIGURE 60 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2020)
11.1.7 NEOGEN CORPORATION
TABLE 159 NEOGEN CORPORATION: BUSINESS OVERVIEW
FIGURE 61 COMPANY SNAPSHOT: NEOGEN CORPORATION (2020)
11.1.8 HIMEDIA LABORATORIES
TABLE 160 HIMEDIA LABORATORIES: BUSINESS OVERVIEW
11.1.9 MAST GROUP LTD.
TABLE 161 MAST GROUP LTD.: BUSINESS OVERVIEW
11.1.10 BIOGUARD CORPORATION
TABLE 162 BIOGUARD CORPORATION: BUSINESS OVERVIEW
11.1.11 SSI DIAGNOSTICA A/S
TABLE 163 SSI DIAGNOSTICA A/S: BUSINESS OVERVIEW
11.1.12 CONDALAB
TABLE 164 CONDALAB: BUSINESS OVERVIEW
11.1.13 FASTINOV SA
TABLE 165 FASTINOV SA: BUSINESS OVERVIEW
11.1.14 SYNBIOSIS
TABLE 166 SYNBIOSIS: BUSINESS OVERVIEW
11.1.15 HARDY DIAGNOSTICS
TABLE 167 HARDY DIAGNOSTICS: BUSINESS OVERVIEW
11.1.16 LIOFILCHEM SRL.
TABLE 168 LIOFILCHEM SRL: BUSINESS OVERVIEW
11.2 DEMAND-SIDE PLAYERS
11.2.1 IDEXX REFERENCE LABORATORIES
TABLE 169 IDEXX LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 62 COMPANY SNAPSHOT: IDEXX LABORATORIES, INC. (2020)
11.2.2 UNIVERSITY OF MINNESOTA (VETERINARY DIAGNOSTIC LABORATORY)
11.2.3 IOWA STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY)
11.2.4 CORNELL UNIVERSITY (ANIMAL HEALTH DIAGNOSTIC CENTER)
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
